Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates  by Ferreira, Joao Leandro de Paula et al.
E
o
J
G
L
A
A
R
R
A
A
K
H
V
P
V
C
B
1
t
e
M
t
o
v
r
t
b
g
q
c
o
r
0
dJournal of Virological Methods 179 (2012) 325– 329
Contents lists available at SciVerse ScienceDirect
Journal  of  Virological  Methods
jou rn al h om epage: www.elsev ier .com/ locate / jv i romet
valuation  of  genotypic  prediction  of  HIV-1  tropism  using  population  sequencing
f  replicates
oao  Leandro  de  Paula  Ferreira, Luana  Portes  Ozorio  Coelho,  Rosangela  Rodrigues,
abriela  Bastos  Cabral,  Jaqueline  de  Souza  Cavalcanti,  Paula  Morena  de  Souza  Guimaraes,
uis Fernando  de  Macedo  Brigido ∗
dolfo Lutz Institute, Virology Center, Retrovirus Laboratory, Sao Paulo, Brazil
rticle history:
eceived 15 July 2011
eceived in revised form 31 October 2011
ccepted 9 November 2011
vailable online 26 November 2011
eywords:
IV-1
iral tropism
CR
a  b  s  t  r  a  c  t
Determination  of  human  immunodeﬁciency  virus  tropism  has  contributed  to  the  understanding  of  the
pathogenesis  of HIV  and  is necessary  prior  to  the  use  of  CCR5  antagonists.  Replicate  V3 sequences  may
generate  different  sequences  and  improve  viral  tropism  prediction.  The  diversity  of  HIV  was  evaluated
to  access  its  inﬂuence  on  prediction.  Plasma  RNA  was  retro-transcribed  and  ampliﬁed  using a  one-step
protocol,  followed  by nested  PCR  and  sequencing  using  an ABI3130XL.  Eighty-one  patients,  74%  male
and  26%  female,  with  a  median  age  of  44 years  had  either  a single  sequence  (n  = 50)  or  2–4 replicates
(n  =  31) evaluated.  Most  patients  (92%)  had used  multiple  anti-retroviral  regimens.  Tropism  prediction
was  performed  using  the Geno2pheno  clonal  option.  The  number  of  ambiguous  nucleotides,  the deduced
non-synonymous  amino  acids  at  V3  and  the  genetic  distance  were  quantiﬁed.  Using  a  20%  false  positive
3irion
o-receptors
razil
rate (FPR)  cut-off,  41/81  (50.6%)  was  predicted  as X4.  TCD4  was  lower,  226  cells/mm (IQR  82–378),
in  patients  infected  with  X4;  TCD4  for R5  was  324  cells/mm3 (IQR  200–538,  p  < 0.05).  The number  of
ambiguous  nucleotides  correlated  with  a lower  FPR  value  (p  <  0.0027).  Although  different  sequences  may
be generated,  the  number  of replicates  was  not  associated  to a lower  FPR  or X4  assignment,  and  may
allow  a better  prediction  of  this  biological  characteristic.  Ambiguous  nucleotides  correlate  inversely  to  a
lower FPR.
. Introduction
The study of HIV-1 (human immunodeﬁciency virus type 1)
ropism has contributed to the understanding of viral pathogen-
sis (Fenyö et al., 1989; Koot et al., 1993; Shepherd et al., 2008).
ore recently, the development of CCR5 antagonists has made
ropism determination necessary to prescribe these drugs as part
f anti-retroviral combination therapies (FDA, 2007). Although
iral phenotype assays are available commercially and at several
esearch facilities, cost and other considerations make genotypic
ropism prediction an interesting alternative.
Similar to many other RNA viruses, HIV biology is characterised
y variability. Therefore, HIV should not be referred to as a sin-
le viral isolate but rather as a swarm of similar variants or a
uasispecies (Nowak et al., 1990; Lauring and Andino, 2010); a
loud of diversity around a master sequence. It is thought that
nly single or a few variants are able to establish infection in a
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new host (Fischer et al., 2010). Genetic distance within the qua-
sispecies population increases during the infection, both diverging
from the initial inoculate as well as displaying more heterogeneity
among the different variants (Shankarappa et al., 1999). The abil-
ity to identify this diversity in patients during the chronic stage
of the disease is a limitation of genotypic tests that depend upon
population sequencing.
Direct population sequencing allows the study of the major
variant. The sequencing of HIV clones and, more recently, deep
sequencing (Fischer et al., 2010) has allowed a much broader delin-
eation of the variability present in a given HIV quasispecies. These
methods, however, are complex and impractical for the clinical lab-
oratories that perform sequencing assays to assist clinical decision,
especially in settings with limited resources. An alternative would
be to amplify, in independent reactions, the RNA present in the sam-
ple, allowing the sequencing of more variants and consequently
better representing the original diversity. This methodology was
proposed by the British Columbia Centre for Excellence in HIV/AIDS
has proved useful for the prediction of viral tropism (McGovern
Open access under the Elsevier OA license.et al., 2010). Factors that may  inﬂuence viral tropism prediction
were evaluated and a method is described based on parallel, inde-
pendent retro-transcription, ampliﬁcation and sequencing of viral
RNA.
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Table 1
Clinical and demographic data.
Single sequence Replicate sequence All cases
n 50 31 81
Age  (years) 45 (39–49) 41 (34–47) 44 (38–49)
Gender  (% males) 74% 74% 74%
TCD4  at collection (cells/mm3) 241 (80–420) 305 (186–511) 291 (116–453)
Nadir TCD4 (cells/mm3) 75 (24–128) 106 (38–161) 88 (24–161)
Viral  load at collection (Log10/mL) 3.99 (3.36–4.73) 4.08 (3.54–4.47) 4.05 (3.43–4.61)
Number of ARV regimens 7 (4–9) 8 (5–9) 8 (5–9)
Time  on treatment (years) 11.8 (10.2–13.5) 12.3 (10.6–13.9) 12.0 (10.2–13.6)
Patient characteristics according to number of sequences obtained for this study. n, total number of cases in each group (cases with single sequence, cases with replicates,
a males
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Dnd  all cases studied); age, at the time of collection for tropism test; percentage of 
iral  load; number of ARV, combinations used by the patient; time on ARV therapy
. Materials and methods
.1. Study population
Biological samples included in the study were collected from
atients followed at clinical sites in Sao Paulo state from 2008
o 2010. Patients provided written informed consent obtained at
linical sites by physicians. A report of genotypic tropism predic-
ion was generated to support salvage therapy for patients with
dvanced disease. The study was approved by the Ethical Commit-
ees of the participating institutions. Table 1 lists the characteristics
f the patients.
.2. HIV-1 env genetic sequencing
Plasma collected in EDTA was separated by centrifugation
ithin 6 h of collection and stored at −70 ◦C until analysis. HIV
NA was extracted from plasma using the QIAmp Viral RNA Kit
Qiagen, Hilden, Germany) following the manufacturer’s instruc-
ions. RNA was ampliﬁed in replicates using a nested one-step
everse transcription PCR (RT-PCR) method. Ampliﬁcation of the
IV envelope (env) gene was performed using 2.5 L of RNA tem-
late. The reaction consisted of MgSO4 2 mM,  dNTP’s 10 mM,  DTT
.1 M,  Inhibitor RNAse 10 U, Superscript III 20 U, Taq Platinum High
idelity 0.625 U, buffer and RNAse/DNAse free water, all reagents
rom Invitrogen (USA) with 10 M of each primer SQV3F1, forward
osition 5′-GAG CCA ATT CCC ATA CAT TAT TGT-3′ (6858 → 6878),
nd CO602, reverse position 5′-GCC CAT AGT GCT TCC TGC TGC TCC
AA GAA CC-3′ (7814 ← 7786). The ﬁnal volume was  25 L. Posi-
ive and negative controls were included in each experiment. PCR
ycle conditions consisted of 50 ◦C for 30 min  and 94 ◦C for 2 min,
ollowed by 40 cycles of 94 ◦C for 15 s, 55 ◦C for 30 s, 68 ◦C for 1 min
0 s, and 68 ◦C for 10 min. Five microlitres of RT-PCR product was
sed in a second PCR (nested) with primers SQV3F2, forward posi-
ion 5′-TGT GCC CCA GCT GGT TTT GCG AT-3′ (6879 → 6898), and
D4R, reverse position 5′-TAT AAT TCA CTT CTC CAA TTG TCC-3′
7652 ← 7672), with Go Taq Green Master Mix  (Promega, USA) in
 ﬁnal volume reaction of 50 L. PCR cycle conditions consisted of
0 cycles of 94 ◦C for 2 min, 10 cycles 94 ◦C for 15 s, 55 ◦C for 30 s,
2 ◦C for 1 min, 25 cycles of 94 ◦C for 15 s, 55 ◦C for 30 s, 72 ◦C for
 min  (increasing by 5 s in each sequential elongation), with a ﬁnal
longation period of 72 ◦C for 7 min. PCR reactions were considered
alid when both the PCR products and the positive control bands
ere observed at approximately 700 bp when separated on a 1.3%
garose gel and visualised with SYBR Safe DNA gel staining (Invit-
ogen, USA) along with controls. Some of the single sequences were
btained using a previously published nested PCR protocol based on
he WHO  guideline recommendations (Ferreira et al., 2008). Nested
CR products were quantiﬁed using a low DNA mass ladder (Invit-
ogen, USA) diluted (1:10) in water to allow an input of 5–10 ng of
NA for rhodamine incorporation. The Big Dye Kit (Ready Reaction; TCD4 counts at collection; TCD4 nadir, value documented throughout follow-up;
rs.
Mix, Applied Biosystems, Foster City, CA) was used for sequenc-
ing with the primers V3O2, forward position 5′-AAT GTC AGY ACA
GTA CAA TGT ACA C-3′ (6948 → 6969), ES7, forward position 5′-CTG
TTA AAT GGC AGT CTA GC-3′ (7005 → 7021), ED33, reverse posi-
tion 5′-TTA CAG TAG AAA AAT TCC CCT C-3′ (7360 ← 7378), and
SQV3, reverse position 5′-GAA AAA TTC CCT TCC ACA ATT AAA-3′
(7350 ← 7370). Cycle sequencing conditions consisted of 25 cycles
at 96 ◦C for 10 s, 50 ◦C for 5 s, 60 ◦C for 4 min, 8 ◦C for an undeter-
mined length of time. After cycling, DNA was precipitated using a
solution of sodium acetate and ethanol, followed by denaturation
using Hi-Di Formamide at 94 ◦C for 4 min. Sequences were deter-
mined with an automated sequencer (Genetic Analyzer 3130 XL,
Applied Biosystems).
2.3. Tropism prediction
Electropherogram data were analysed using Sequencher 4.6
software. Sequences were edited manually, and a consensus
was generated based on two or more sequences and included
ambiguous nucleotides (mixtures). Sequence quality control and
preliminary subtyping was performed using the web-based tools
NCBI locator, BLAST and NCBI Genotyping, referring back to
the electropherograms as needed. The co-receptor used by HIV-
1 was predicted from the V3 env region nucleotide sequence
by Geno2pheno (URL: http://coreceptor.bioinf.mpi-sb.mpg.de/cgi-
bin/coreceptor.pl).  The determination of tropism was obtained by
submitting the sequences (FASTA format) to Geno2pheno using the
clonal option, which relies on ranking of the submitted sequences
to a curate data set. A false positive rate (FPR), the probability of
falsely classifying an R5-virus as X4, was assigned to each submit-
ted sequence. These rates, using the lower FPR from all sequences
obtained, allowed us to determine the likelihood of each sequence
tropism prediction as well as the patients’ HIV infection population
tropism prediction as recommended by the European consensus
(Vandekerckhove et al., 2011).
2.4. Distance metrics
An estimation of diversity at V3 of each sequence (intra-
sequence) was  evaluated as follows: (i) the number of ambiguous
nucleotides; (ii) the number of all possible amino acids coded by
ambiguities allowing for non-synonymous mixtures (NSM); and
(iii) the number of amino acid positions (codons) at V3 with NSM.
The diversity of sequences between replicates (inter-sequence)
was quantiﬁed by Prodist, which computes a distance matrix from
protein sequences taking into account a variety of sequence ambi-
guities, and Gendist, which uses nucleotide sequences to compute
a distance matrix, using Bioedit software. Bootstrap support was
used for phylogenetic tree nodes, and 1000 replicates were con-
structed using Paup4 by applying the evolution model selected
using Modeltest (GTR+I+G). Epi6 was  used for data management,
irological Methods 179 (2012) 325– 329 327
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Fig. 1. Representative maximum likelihood phylogenetic tree of partial enve-
lope region sequences of the study, constructed according to evolutionary model
(GTR+I+G) as selected at Modeltest (PAUP* v4.0b10). References HIV-1 subtypes
were obtained from the Los Alamos HIV Sequence Database. Bootstrap values (1000
replicates) at key branches are depicted. Sequences from study are designated by ID
number, a letter (e.g. a,b,c) for each sequence in cases with replicates and designated
as  X4 or R5 according to the Geno2pheno tropism prediction of each sequence using
a  false positive rate of 20%, clonal option.J.L.d.P. Ferreira et al. / Journal of V
tudent’s t-test, Mann–Whitney U-test and linear correlations
Spearman) were performed using GraphPad Prism. The results are
xpressed as medians, 25th and 75th percentiles (IQR), with a level
f signiﬁcance of p < 0.05.
. Results
Env sequences were obtained from 81 patients, 74% male, with
 median age of 44 years. Most (92%) were on anti-retroviral treat-
ent (ARV) but were not exposed to CCR5 antagonists, and 8% were
aïve to all ARV. Patients on ARV were heavily treated, exposed
t collection to a median of 8 different regimens (3–14) during a
edian treatment period of 12 years (10–13). The median viral
oad was 4.05 Log10 and TCD4 263 cells/mm3. From 50 patients’
ases, a single env sequence was obtained, and from 31 cases a
edian of 4 replicates (2–4) were obtained (Table 1). The use of a
ne-step protocol, using three independent PCR reactions, carried
ut on plasma RNA extracted from samples with viraemia (over
000 copies/mL), allowed the evaluation of three sequences in 78%
f cases, two sequences in 16% of cases, and one sequence in 6%
f cases. Overall, 41/81 (50.6%) were predicted as X4 tropic using a
0% FPR cut-off. TCD4 was signiﬁcantly lower among cases infected
ith variants predicted as X4, TCD4 226 cells/mm3 (IQR 82–378),
ompared with R5, TCD4 324 cells/mm3 (IQR 200–538, p < 0.05).
The diversity between replicates (inter-sequence) at V3 varied;
 representative phylogenetic tree is shown in Fig. 1. Samples from
he same patient grouped within clusters that were supported by
ootstrap from 74% to 100%. Out of 31 V3 sequence replicates,
0.6% had some nucleotide or nucleotide ambiguity difference, and
4.5% of replicate sets had one or more amino acid or NSM differ-
nce. The median genetic distance was zero (IQR 0.0–0.0098) and
he median protein distance was 0.045 (IQR 0.011–0.089). Within
ach sequence (intra-sequence diversity), the median number of
mbiguous nucleotides was 0.95 (IQR 0–2.85) and was similar for
oth singles and replicates. The median number of NSM or codons
ith NSM was  zero (IQR 0–2) and was slightly higher, but not signif-
cantly, for replicates (p = 0.2 and p = 0.3, respectively). As expected,
he number of ambiguities correlated strongly to the number of
SM (p < 0.0001). There was no correlation between either inter
r intra-sequence diversity and TCD4 values or viral load; how-
ver, although it was not signiﬁcant (p = 0.3), the protein distance
ppeared to decrease with viral load and increase with TCD4 counts
Fig. 2).
.1. Value FPR
False positive rates, as well as X4 or R5 prediction by dichotomi-
ation at 20% FPR, were inversely correlated to both ambiguities
nd NSM (p < 0.0001). When sequences with a high number of
mbiguities (6 or more ambiguous bases) were removed from the
nalysis, this correlation was still observed (p = 0.0027, Fig. 3). The
nter-replicate protein distance showed some association to X4
rediction (p = 0.055, Fig. 4). However, the number of replicates did
ot correlate to either a lower predicted FPR of a replicate set or to
he individual FPR obtained for each sequence (Fig. 5).
. Discussion
This study evaluated a protocol for the ampliﬁcation of replicate
opulation (bulk) sequencing from plasma samples. We  describe a
ethod for one-step RT-PCR using reagents that may  facilitate itsmplementation in settings with limited resources. The analysis and
he sequence interpretation of genotypic tropism is a crucial step.
ropism prediction may  be performed using tools on different web-
ites and by inspection of the sequences, as using the “11/25 rule”,
328 J.L.d.P. Ferreira et al. / Journal of Virological Methods 179 (2012) 325– 329
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Fig. 2. TCD4 values, cells/mm3 (A, B) and viral load, Log10/mL, (C, D) along with numbe
(Spearman) r and p value is shown at top right.
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Fig. 3. False positive rate (FPR), obtained at clonal option of Geno2pheno website
along with number of ambiguities. Only sequences with less than 6 ambiguities at
V3 loop are shown. Linear correlation (Spearman) r and p value is shown at top right.
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Fig. 4. Average protein distance according to assigned predicted viral phenotype
CXCR4 (X4) or CCR5 (R5) using a false positive rate (FPR) of 20% cut-off for catego-
rization.r of ambiguities (A, C) and genetic and protein distance (B, D). Linear correlation
based in the identiﬁcation of basic side chains in residues 11 or 25.
Here, we  did not evaluate all methods of sequence interpretation,
but instead aimed to simplify the evaluation and analysis of the
sequence parameters described here with the Max  Planck resource,
Geno2pheno (clonal option). It is a user-friendly tool, allowing the
evaluation of sequences with ambiguous nucleotides. A European
consensus has recently recommended its use, establishing differ-
ential cut-offs for single and replicate sequences when applying the
test for clinical use, and considering the lower FPR for viral tropism
prediction when replicates implicate different FPRs for a sequence
set (Vandekerckhove et al., 2011).
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Fig. 5. V3 sequence false positive rate (FPR), or the lower FPR for replicates, accord-
ing  to the number of sequence analysed in each case, as one (single sequence) up to
four replicates from same plasma sample.
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Vandekerckhove, L., Wensing, A., Kaiser, R., Brun-Vézinet, F., Clotet, B., De Luca, A.,
Dressler, S., Garcia, F., Geretti, A., Klimkait, T., Korn, K., Masquelier, B., Perno, C.,J.L.d.P. Ferreira et al. / Journal of V
The lowest cut-off for deﬁning the presence of X4 variants with
eplicates was proposed by the Vancouver group (McGovern et al.,
010) after a retrospective evaluation of the Motivate study results.
his study deﬁned X4 cases as having an FPR below 2%, possible X4
ith an FPR from 2% to 5.75% and R5 for cases with an FPR above
.75%. The European consensus suggests a cut-off of 10% for cases
ith replicates and a 20% cut-off for single sequences. We  used the
onservative 20% cut-off in this study. Although some of the single
equences were obtained using different primers, as suggested by
HO  guidelines, edition and tropism interpretation were the same
s those used for replicates. Sequences were evaluated both indi-
idually and as replicates. Our aim was to better understand the role
f independent ampliﬁcation of replicates on the FPR. Therefore, we
ompared predictions inferred from both single and replicate (2–4)
equences to evaluate parameters that may  inﬂuence viral tropism
rediction. We  also evaluated the FPR value as a continuous variable
o evaluate its correlation to viral diversity metrics.
The use of replicates to predict viral tropism poses the ques-
ion of whether the number of sequences alone could increase the
ikelihood of ﬁnding an X4 tropic variant. It may  be suggested that
he higher the replicate number, the more likely is the chance of
etecting an X4 virus. This would represent an X4 classiﬁcation
econdary to the number of replicates. Indeed, this is a problem
n “deep sequencing”, where a cut-off is deﬁned (Swenson et al.,
011), above which the identiﬁcation X4 is assumed to be “real”.
s shown in Fig. 5, the number of replicates does not correlate
o a lower FPR or to the likelihood of detecting X4 viruses. We
id, however, ﬁnd a strong correlation between some diversity
arameters and the prediction of X4 populations. In this study,
he potential diversity generated intra-sequence, as the genetic and
rotein distance among replicates, suggested an inverse correlation
o FPR. When FPR results were separated as either X4/R5 viruses,
 weak association of X4 to higher protein distance was observed
p = 0.055). Moreover, the presence of ambiguous nucleotides, as
ell as ambiguities that would code for non-synonymous amino
cid mixtures, shows a strong inverse correlation to a lower FPR
p < 0.0001). These ambiguities are also signiﬁcantly higher among
4 viruses. The quality of a sequence may  also increase the chance
f assigning a base as an ambiguous nucleotide, and consequently
 non-biological increase in the probability of different deduced
mino acids. Sequences were carefully revised and evaluated for
uality to minimise this possibility. Furthermore, when cases with
igher numbers of ambiguities were excluded (e.g. over 6 ambigu-
ties at V3), the number of ambiguities still associated to X4 viruses
nd showed an inverse correlation to FPR (Fig. 3).
Ambiguities in nucleotide assignments at sequences that may
ode for more than one amino acid are considered both in the
rediction of genotype resistance from the polymerase gene, as
ell as in tropism prediction from envelope genes. Some bioinfor-
atics tools resolve these uncertainties and describe all possible
ucleotide translations, thereby facilitating sequence interpreta-
ion. Manual revision further allows the correct interpretation of
equence information. Population sequencing allows the study of
he most represented variant within the actual quasispecies in a
iven individual, and the identiﬁcation of ambiguous nucleotides
uggests the presence of more diverse populations (Kouyos et al.,
011) or of a co-infection (Cornelissen et al., 2007). Moreover, ambi-
uity has also been correlated to X4 variants using deep sequencing
Abbate et al., 2011). A longer period of infection is associated to
n X4 tropism, and the larger diversity within the quasispecies of
n older infection could increase the probability of having X4 vari-
nts. It is possible that the weighing of ambiguities by the time of
nfection might improve prediction; our study cannot discount this
ossibility.
The fact that we compared replicates with singles from different
atients hinders comparability, and paired experiments amplifyingcal Methods 179 (2012) 325– 329 329
unique or multiple sequences would be more precise. However, as
the conditions of ampliﬁcation, sequencing and interpretation were
similar in both groups, the evaluation of individual sequences from
cases with more than one sequence and the random assignments
of patients to either single or replicate groups compensate in part
to overcome this limitation.
In conclusion, the presence of ambiguous nucleotides and non-
synonymous amino acid mixtures at the sequence level, and to
some extent the distance between replicate sequences, correlates
to a lower FPR and consequently to X4 viral tropism prediction.
More importantly, the number of replicates did not lead to a lower
FPR or an increase in X4 prediction, suggesting that replicates
do not randomly increase the chance of identifying an X4 tropic
variant, but rather allow a better identiﬁcation of this biological
characteristic. However, although these clinical cut-offs are use-
ful to guide CCR5 antagonist use in clinical practice, the extent to
which the quasispecies must be assessed to predict adequately X4
tropic behaviour requires further investigation.
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